370 related articles for article (PubMed ID: 23744740)
1. CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism.
Peterson JM; Seldin MM; Wei Z; Aja S; Wong GW
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(3):G214-24. PubMed ID: 23744740
[TBL] [Abstract][Full Text] [Related]
2. CTRP3 deficiency reduces liver size and alters IL-6 and TGFβ levels in obese mice.
Wolf RM; Lei X; Yang ZC; Nyandjo M; Tan SY; Wong GW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E332-45. PubMed ID: 26670485
[TBL] [Abstract][Full Text] [Related]
3. Transgenic overexpression of CTRP3 prevents alcohol-induced hepatic triglyceride accumulation.
Trogen G; Bacon J; Li Y; Wright GL; Degroat A; Hagood KL; Warren Z; Forsman A; Kilaru A; Clark WA; Peterson JM
Am J Physiol Endocrinol Metab; 2018 Nov; 315(5):E949-E960. PubMed ID: 29763374
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory roles of CTRP3 in endotoxemia and metabolic stress.
Petersen PS; Wolf RM; Lei X; Peterson JM; Wong GW
Physiol Rep; 2016 Mar; 4(5):. PubMed ID: 26997632
[TBL] [Abstract][Full Text] [Related]
5. C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output.
Peterson JM; Wei Z; Wong GW
J Biol Chem; 2010 Dec; 285(51):39691-701. PubMed ID: 20952387
[TBL] [Abstract][Full Text] [Related]
6. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
7. Loss of CTRP1 disrupts glucose and lipid homeostasis.
Rodriguez S; Lei X; Petersen PS; Tan SY; Little HC; Wong GW
Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E678-E697. PubMed ID: 27555298
[TBL] [Abstract][Full Text] [Related]
8. C1q/TNF-related protein 3 expression and effects on adipocyte differentiation of 3T3-L1 cells.
Nishimoto H; Yamamoto A; Furukawa S; Wakisaka S; Maeda T
Cell Biol Int; 2017 Feb; 41(2):197-203. PubMed ID: 27590487
[TBL] [Abstract][Full Text] [Related]
9. Transgenic overexpression of CTRP3 does not prevent alcohol induced hepatic steatosis in female mice.
Thomas KL; Root CL; Peterson JM
PLoS One; 2022; 17(1):e0258557. PubMed ID: 34995284
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
11. Alterations of hepatic gluconeogenesis and amino acid metabolism in CTRP3-deficient mice.
Maeda T
Mol Biol Rep; 2022 Feb; 49(2):1617-1622. PubMed ID: 34811637
[TBL] [Abstract][Full Text] [Related]
12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
13. CTRP12 ablation differentially affects energy expenditure, body weight, and insulin sensitivity in male and female mice.
Tan SY; Lei X; Little HC; Rodriguez S; Sarver DC; Cao X; Wong GW
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E146-E162. PubMed ID: 32421370
[TBL] [Abstract][Full Text] [Related]
14. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
[TBL] [Abstract][Full Text] [Related]
15. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
[TBL] [Abstract][Full Text] [Related]
16. Catalpol induces autophagy and attenuates liver steatosis in ob/ob and high-fat diet-induced obese mice.
Ren H; Wang D; Zhang L; Kang X; Li Y; Zhou X; Yuan G
Aging (Albany NY); 2019 Nov; 11(21):9461-9477. PubMed ID: 31697646
[TBL] [Abstract][Full Text] [Related]
17. Partial deficiency of CTRP12 alters hepatic lipid metabolism.
Tan SY; Little HC; Lei X; Li S; Rodriguez S; Wong GW
Physiol Genomics; 2016 Dec; 48(12):936-949. PubMed ID: 27815536
[TBL] [Abstract][Full Text] [Related]
18. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
